VEGFA and pulmonary fibrosis: Transfection of anti-VEGF gene therapy, in the form of the sFlt-1 gene, resulted in the attenuation of pulmonary fibrosis with a reduction of collagen deposition and additional anti-inflammatory and anti-angiogenic effects [37].